Holen Sie sich die Stockscreener-App
98.04
1.20%
1.16
Vorhandelsmarkt:
98.39
0.35
+0.36%
Schlusskurs vom Vortag:
$96.88
Offen:
$96.29
24-Stunden-Volumen:
17.52M
Relative Volume:
1.88
Marktkapitalisierung:
$145.34B
Einnahmen:
$19.35B
Nettoeinkommen (Verlust:
$2.78B
KGV:
52.44
EPS:
1.8696
Netto-Cashflow:
$3.82B
1W Leistung:
-3.66%
1M Leistung:
-3.04%
6M Leistung:
-6.18%
1J Leistung:
+8.93%
1-Tages-Spanne:
$96.13
$98.28
1-Wochen-Bereich:
$95.98
$101.89
52-Wochen-Spanne:
$85.98
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Vergleichen Sie BSX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
98.04 | 143.62B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
ABT
Abbott Laboratories
|
127.19 | 222.77B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
370.22 | 140.84B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
103.20 | 129.80B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
84.71 | 49.40B | 5.88B | 1.34B | 799.60M | 2.3489 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-03 | Herabstufung | Erste Group | Buy → Hold |
| 2025-09-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-16 | Hochstufung | Needham | Hold → Buy |
| 2025-01-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Boston Scientific (NYSE:BSX) Trading Volume Rises After Sector-Focused Report - Kalkine Media
Analysts project durable growth with many near-term catalysts for Boston Scientific - MassDevice
BTIG Reiterates Boston Scientific (BSX) Buy Recommendation - Nasdaq
Internal Neuromodulation Devices Market Poised to Exceed USD 44.57 Billion by 2033 | Astute Analytica - GlobeNewswire Inc.
Can Boston Scientific Corporation stock sustain institutional flowsMarket Activity Report & AI Driven Stock Reports - newser.com
Will Boston Scientific Corporation stock benefit from automation - newser.com
Is Boston Scientific Corporation stock undervalued after correctionJuly 2025 Big Picture & Safe Entry Momentum Tips - newser.com
Boston Scientific (BSX) Announces 2026 Compensation Plans to Dri - GuruFocus
Boston Scientific, Epic collaborate on cardiac diagnostic EHR services - MassDevice
Boston Scientific Approves 2026 Bonus Plan - TipRanks
Boston Scientific Corp. Stock Outperforms Competitors Despite Losses On The Day - 富途牛牛
[8-K] BOSTON SCIENTIFIC CORP Reports Material Event | BSX SEC FilingForm 8-K - Stock Titan
Boston Scientific (BSX) Stock Today: Price Slips as Neuromodulation Bull Case, Epic EHR Deal and Big Fund Moves Shape the Outlook – November 19, 2025 - ts2.tech
Siemens partners with Boston Sci, eyes standalone growth - BioWorld MedTech
Using AI based signals to follow Boston Scientific Corporation2025 Performance Recap & Advanced Technical Analysis Signals - newser.com
Can Boston Scientific Corporation stock deliver consistent EPS growth2025 Sector Review & Daily Chart Pattern Signal Reports - newser.com
Does Boston Scientific Corporation stock trade at a discount to peersWeekly Volume Report & Entry and Exit Point Strategies - newser.com
Boston Scientific at Wolfe Conference: Innovation and Market Growth - Investing.com
Wall Street Analysts Believe Boston Scientific (BSX) Could Rally 25.34%: Here's is How to Trade - Finviz
Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion - Nasdaq
Can Boston Scientific Corporation recover in the next quarterNew Guidance & Free Accurate Trade Setup Notifications - newser.com
Why Boston Scientific Corporation stock is favored by hedge fundsWeekly Trade Report & Free High Accuracy Swing Entry Alerts - newser.com
2 Reasons to Watch BSX and 1 to Stay Cautious - Finviz
What earnings revisions data tells us about Boston Scientific Corporation2025 Retail Activity & Risk Controlled Daily Trade Plans - newser.com
Is Boston Scientific's Valuation Justified After 18% Gain and New Product Launches? - Yahoo Finance
What Boston Scientific (BSX)'s Surging Sales and Siemens Partnership Mean for Shareholders - Yahoo! Finance Canada
[Form 4] BOSTON SCIENTIFIC CORP Insider Trading Activity - Stock Titan
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Boston Scientific gains US distribution duties for Siemens Healthineers’ ICE catheter - Yahoo Finance
Boston Scientific Up 7% in a Month: How Should You Play the Stock? - Finviz
Can Boston Scientific Corporation stock test all time highsQuarterly Portfolio Report & Weekly High Conviction Ideas - newser.com
UBS Boosts Boston Scientific (BSX) Price Target After Strong Q3 Earnings - Insider Monkey
Boston Scientific, Siemens Healthineers ink 4D ICE catheter development deal - MassDevice
Boston Scientific enrolls first patient in AFib mapping study using OptiMap, Farapulse - MassDevice
Boston Scientific (BSX) Crossed Above the 200-Day Moving Average: What That Means for Investors - Yahoo Finance
Investors more bullish on Boston Scientific (NYSE:BSX) this week as stock grows 3.7%, despite earnings trending downwards over past five years - Yahoo Finance
CLOSURE-AF study not the end of the line for LAAC devices - BioWorld MedTech
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet - Yahoo Finance
If You Invested $1000 in Boston Scientific a Decade Ago, This is How Much It'd Be Worth Now - Yahoo Finance
Is Boston Scientific (BSX) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.53%
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):